Skip to main content
Signal8

Rosenberg Noah L.

SEC insider (Form 3/4/5 filer). CIK 0001579649. CMO at Verrica Pharmaceuticals Inc. (VRCA). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in WEST CHESTER, PA.

Companies Rosenberg Noah L. has filed insider reports for

  • Verrica Pharmaceuticals Inc. (VRCA): Officer, CMO
Rosenberg Noah L. profile photo

Rosenberg Noah L.

CIK: 0001579649

Transaction Breakdown

Open Market Buys (P)3 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Verrica Pharmaceuticals Inc. logo
VRCA

Verrica Pharmaceuticals Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Verrica Pharmaceuticals Inc. logo
    VRCA

    Verrica Pharmaceuticals Inc.

    Aug 18, 2026
    Purchase
    Direct
    2K shares at avg. $4.92$10K
  • Verrica Pharmaceuticals Inc. logo
    VRCA

    Verrica Pharmaceuticals Inc.

    Aug 17, 2026
    Purchase
    Direct
    4.2K shares at avg. $4.91$21K
  • Verrica Pharmaceuticals Inc. logo
    VRCA

    Verrica Pharmaceuticals Inc.

    Jun 5, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    233.8K shares-
  • Verrica Pharmaceuticals Inc. logo
    VRCA

    Verrica Pharmaceuticals Inc.

    Nov 25, 2025
    Purchase
    Direct
    2.4K shares at avg. $4.24$10K
  • Verrica Pharmaceuticals Inc. logo
    VRCA

    Verrica Pharmaceuticals Inc.

    Mar 24, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    325K shares-

1-5 of 5